Alkem Laboratories Limited is one of India’s leading pharmaceutical companies engaged in the development, manufacturing, and commercialization of branded generics, generic medicines, nutraceuticals, and active pharmaceutical ingredients. Established in 1973, the company has built a strong presence across India and more than 50 international markets. Alkem offers an extensive portfolio covering anti-infectives, gastroenterology, pain management, cardiology, neurology, diabetes, dermatology, and oncology. The company operates numerous manufacturing facilities and research centers that comply with international regulatory standards, supporting exports to regulated and emerging markets. Alkem continues to strengthen its specialty and chronic therapy businesses while expanding its global footprint through innovation and strategic partnerships. Its commitment to quality manufacturing, continuous research, and affordable healthcare has positioned the company among India’s top pharmaceutical manufacturers. By combining scientific expertise with customer-focused solutions, Alkem continues to address evolving healthcare needs across diverse therapeutic segments.
NSE: ALKEM | BSE: 539523
Mumbai, Maharashtra, India
~16,000 employees
